PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:31 AM ET

Sponsor Check › Person

AD
No photo found yet (own website and image search run after this page is viewed)

Ann DeWitt

Named as an officer, director or promoter on SEC Form D filings · MA · Feb 1, 2017 → Mar 19, 2026

10deals (issuers)
$378.8Mreported sold
285investors
36Form D filings
2017–2026years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:38 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Ann DeWitt is listed as a director on 36 SEC Form D filings by 10 issuers between Feb 2017 and Mar 2026. Largest by amount reported sold: Quaise Energy, Inc. (Houston, TX — other energy — 2020–2023; $179.3M reported sold to 49 investors), Terrestrial Bio, Inc. (Woburn, MA — biotechnology — 2021–2026; $57.3M reported sold to 16 investors), Cambridge Crops, Inc. (Charlestown, MA — industry reported as "Other" — 2019–2022; $50M reported sold to 24 investors), Kytopen Corp. (Cambridge, MA — biotechnology — 2019–2020; $32.5M reported sold to 22 investors), Biobot Analytics, Inc. (Cambridge, MA — other technology — 2021; $20.8M reported sold to 46 investors) and 5 more (all listed below).

What this means That is a lot of deals — 10 separate companies raised money with this person listed as director, over about 9 years. Across those companies the filings report $378.8M sold in total.

Listed alongside Livio Valenti (10 shared filings), Jonathan Kluge (8 shared filings), Kathryn Kosuda (8 shared filings), Lynda Tussey (8 shared filings), Fenel Eloi (7 shared filings) and 53 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Ann. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 bankruptcy case matching the name listed in Key records below.

What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 36 public filings for Ann DeWitt and found 8 differences: Form D filed 17 days after the first sale; 4 offerings changed their target amount between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Ann DeWitt has not run yet — it is joining a line of 18,047 names; searches run around the clock at the hosts' allowed rate. Searched so far: 28 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:38 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Ann DeWitt..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

1 case: 1 closed (disposition not in docket feed)

James O. Dewitt and Ann S. Dewitt closed
United States Bankruptcy Court, M.D. Georgia · No. 91-52302 · Filed Jul 3, 1991 · Closed May 14, 1996
Role of Ann S. Dewitt: Debtor · Outcome: Case closed 1996-05-14 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (rare in federal dockets); 2 people with this name in Form D filings; court in GA (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:38 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

8 differences found between the filings for Ann DeWitt (compared 36 filings on Oct 24, 2026)

Note · Jul 30, 2021 – Aug 16, 2021

Form D filed 17 days after the first sale — Quaise Energy, Inc.

The filing says the first sale was Jul 30, 2021. The Form D was filed Aug 16, 2021 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Aug 16, 2021 ↗Quaise Energy, Inc. — PartnerFacts page ↗
Sources
Note · May 22, 2020 – Jun 8, 2020

Form D filed 17 days after the first sale — Quaise Energy, Inc.

The filing says the first sale was May 22, 2020. The Form D was filed Jun 8, 2020 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Jun 8, 2020 ↗Quaise Energy, Inc. — PartnerFacts page ↗
Sources
Note · Jun 28, 2019 – Jul 15, 2019

Form D filed 17 days after the first sale — Lucy Therapeutics, Inc.

The filing says the first sale was Jun 28, 2019. The Form D was filed Jul 15, 2019 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Jul 15, 2019 ↗Lucy Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Apr 6, 2016 – Jun 8, 2022

4 offerings changed their target amount between filings

Offering amount changed between filings — Quaise Energy, Inc. · Offering amount changed between filings — Biobot Analytics, Inc. · Offering amount changed between filings — Lucy Therapeutics, Inc. · Offering amount changed between filings — ImmuneXcite, Inc.

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D/A (earlier) · Feb 10, 2022 ↗Form D/A (later) · Jun 8, 2022 ↗Quaise Energy, Inc. — PartnerFacts page ↗Form D (earlier) · Aug 6, 2021 ↗
Sources
Note · Nov 25, 2015 – Sep 10, 2025

12 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Terrestrial Bio, Inc. (latest filing Sep 10, 2025) · No amendment in the last 12 months on an offering that may still be open — Terrestrial Bio, Inc. (latest filing Feb 26, 2025) · No amendment in the last 12 months on an offering that may still be open — Terrestrial Bio, Inc. (latest filing May 28, 2024) · No amendment in the last 12 months on an offering that may still be open — Droplet Biosciences, Inc. (latest filing Dec 13, 2023) · No amendment in the last 12 months on an offering that may still be open — Quaise Energy, Inc. (latest filing Dec 12, 2023) · and 7 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Sep 10, 2025 ↗Terrestrial Bio, Inc. — PartnerFacts page ↗Form D · Feb 26, 2025 ↗Form D · May 28, 2024 ↗
Sources
Note · Aug 19, 2019 – Nov 17, 2022

Same name, different state: "Ann DeWitt" (TX) is a separate record

This page covers filings where the address state is MA. A separate record, "Ann DeWitt" with address state TX, is listed on 4 filings — most recently by Syzygy Plasmonics Inc. (Nov 17, 2022). Both records have filings in the same period (Aug 19, 2019 to Nov 17, 2022).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Ann DeWitt (TX) — PartnerFacts page ↗Form D · Nov 17, 2022 ↗Syzygy Plasmonics Inc. — PartnerFacts page ↗Ann DeWitt (MA) — this page ↗
Sources
Note · Apr 6, 2016 – Sep 10, 2025

4 address changes between filings

Address moved from Cambridge, MA to Woburn, MA — Terrestrial Bio, Inc. · Address moved from Golden, CO to Cambridge, MA — Droplet Biosciences, Inc. · Address moved from Somerville, MA to Charlestown, MA — Cambridge Crops, Inc. · Address moved from Lexington, MA to Waltham, MA — ImmuneXcite, Inc.

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Form D · Feb 26, 2025 ↗Form D · Sep 10, 2025 ↗Terrestrial Bio, Inc. — PartnerFacts page ↗Form D · May 28, 2021 ↗
Sources
Note · Aug 9, 2019 – Jul 16, 2020

Reported revenue range changed between filings — Cambridge Crops, Inc.

"Not Applicable" (Aug 9, 2019); then "Decline to Disclose" (Jul 16, 2020).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Aug 9, 2019 ↗Form D · Jul 16, 2020 ↗Cambridge Crops, Inc. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

0 of 31 offerings report sales commissions; 0 report finder's fees; 2 report proceeds to related persons totalling $697,500. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Mar 19, 2026 D
Terrestrial Bio, Inc.
File 021-577032
$0$0$0None listed on this filingEDGAR ↗
Sep 10, 2025 D
Terrestrial Bio, Inc.
File 021-557195
$0$0$0None listed on this filingEDGAR ↗
Feb 26, 2025 D
Terrestrial Bio, Inc.
File 021-539282
$0$0$0None listed on this filingEDGAR ↗
May 28, 2024 D
Terrestrial Bio, Inc.
File 021-514374
$0$0$0None listed on this filingEDGAR ↗
May 20, 2024 D
Kano Therapeutics Inc.
File 021-513745
$0$0$0None listed on this filingEDGAR ↗
Dec 13, 2023 D
Droplet Biosciences, Inc.
File 021-499503
$0$0$0None listed on this filingEDGAR ↗
Dec 12, 2023 D
Quaise Energy, Inc.
File 021-499321
$0$0$0None listed on this filingEDGAR ↗
Jul 24, 2023 D
Terrestrial Bio, Inc.
File 021-487640
$0$0$0None listed on this filingEDGAR ↗
Dec 23, 2022 D/A
Terrestrial Bio, Inc.
File 021-399415
$0$0$0 (est.)None listed on this filingEDGAR ↗
Oct 4, 2022 D
Terrestrial Bio, Inc.
File 021-460610
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jun 8, 2022 D/A
Quaise Energy, Inc.
File 021-432777
$0$0$0None listed on this filingEDGAR ↗
Mar 9, 2022 D
Cambridge Crops, Inc.
File 021-436441
$0$0$0None listed on this filingEDGAR ↗
Jan 6, 2022 D
Lucy Therapeutics, Inc.
File 021-428117
$0$0$0None listed on this filingEDGAR ↗
Nov 17, 2021 D/A
Biobot Analytics, Inc.
File 021-409119
$0$0$0None listed on this filingEDGAR ↗
Aug 16, 2021 D
Quaise Energy, Inc.
File 021-410083
$0$0$0None listed on this filingEDGAR ↗
Jun 1, 2021 D
E25Bio Inc.
File 021-401199
$0$0$0None listed on this filingEDGAR ↗
May 28, 2021 D
Droplet Biosciences, Inc.
File 021-401080
$0$0$337,500 (est.)None listed on this filingEDGAR ↗
May 27, 2021 D
Cambridge Crops, Inc.
File 021-400894
$0$0$0None listed on this filingEDGAR ↗
Apr 14, 2021 D
Cambridge Crops, Inc.
File 021-395844
$0$0$0None listed on this filingEDGAR ↗
Mar 26, 2021 D
Terrestrial Bio, Inc.
File 021-393660
$0$0$0 (est.)None listed on this filingEDGAR ↗
Nov 6, 2020 D
Kytopen Corp.
File 021-380005
$0$0$0None listed on this filingEDGAR ↗
Jul 22, 2020 D/A
Lucy Therapeutics, Inc.
File 021-344266
$0$0$0None listed on this filingEDGAR ↗
Jul 16, 2020 D
Cambridge Crops, Inc.
File 021-371204
$0$0$0None listed on this filingEDGAR ↗
Jun 8, 2020 D
Quaise Energy, Inc.
File 021-368441
$0$0$0None listed on this filingEDGAR ↗
May 19, 2020 D
E25Bio Inc.
File 021-367294
$0$0$0None listed on this filingEDGAR ↗
Mar 26, 2020 D
E25Bio Inc.
File 021-363714
$0$0$0None listed on this filingEDGAR ↗
Aug 22, 2019 D
E25Bio Inc.
File 021-347179
$0$0$0None listed on this filingEDGAR ↗
Aug 9, 2019 D
Cambridge Crops, Inc.
File 021-346236
$0$0$0None listed on this filingEDGAR ↗
May 24, 2019 D
Kytopen Corp.
File 021-340429
$0$0$0None listed on this filingEDGAR ↗
Feb 1, 2017 D/A
ImmuneXcite, Inc.
File 021-252821
$0$0$360,000 (est.)None listed on this filingEDGAR ↗
Feb 1, 2017 D
ImmuneXcite, Inc.
File 021-279837
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 10

Every issuer that named Ann DeWitt on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

TB
Biotechnology

Terrestrial Bio, Inc.

Woburn, MA · Mar 26, 2021 → Mar 19, 2026 · 9 filings
  • Mar 19, 2026 · D · $57,301,758 sold of $83,538,199 · 16 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 10, 2025 · D · $7,903,411 sold of $10,000,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 26, 2025 · D · $8,400,000 sold of $10,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 28, 2024 · D · $10,775,983 sold of $12,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 24, 2023 · D · $9,096,986 sold of $12,096,986 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 23, 2022 · D/A · $35,012,500 sold of $35,012,500 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 4, 2022 · D · $2,000,000 sold of $2,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 14, 2021 · D · $25,300,000 sold of $35,012,500 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 26, 2021 · D · $2,000,000 sold of $2,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $57.3M from 16 investors (69% of the $83.5M target) as of the latest filing. Ann is listed as director on 9 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

KT
Biotechnology

Kano Therapeutics Inc.

Cambridge, MA · May 20, 2024
  • May 20, 2024 · D · $5,050,000 sold of $5,050,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $5.05M from 4 investors (100% of the $5.05M target) as of the latest filing. Ann is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

DB
Biotechnology

Droplet Biosciences, Inc.

Cambridge, MA · May 28, 2021 → Dec 13, 2023 · 2 filings
  • Dec 13, 2023 · D · $7,613,974 sold of $14,113,973 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 28, 2021 · D · $5,348,980 sold of $5,348,980 · 30 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $7.61M from 30 investors (54% of the $14.1M target) as of the latest filing. Ann is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

QE
Other Energy

Quaise Energy, Inc.

Houston, TX · Jun 8, 2020 → Dec 12, 2023 · 6 filings
  • Dec 12, 2023 · D · $13,079,903 sold of $25,000,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 8, 2022 · D/A · $51,990,988 sold of $51,990,988 · 26 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 10, 2022 · D/A · $39,990,999 sold of $44,990,998 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 8, 2022 · D · $39,990,999 sold of $44,990,998 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 16, 2021 · D · $12,000,000 sold of $12,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 8, 2020 · D · $6,031,890 sold of $6,031,890 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $179.3M from 49 investors (100% of the $25M target) as of the latest filing. Ann is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Energy / 506(b) (1,000 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CC
Other

Cambridge Crops, Inc.

Charlestown, MA · Aug 9, 2019 → Mar 9, 2022 · 5 filings
  • Mar 9, 2022 · D · $49,999,714 sold of $49,999,714 · 24 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 27, 2021 · D · $2,350,000 sold of $2,350,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 14, 2021 · D · $16,000,000 sold of $16,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 16, 2020 · D · $12,000,000 sold of $12,000,000 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 9, 2019 · D · $5,348,594 sold of $5,348,594 · 21 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $50M from 24 investors (100% of the $50M target) as of the latest filing. Ann is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

LT
Pharmaceuticals

Lucy Therapeutics, Inc.

Waltham, MA · Jul 15, 2019 → Jan 6, 2022 · 3 filings
  • Jan 6, 2022 · D · $15,044,707 sold of $20,000,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 22, 2020 · D/A · $3,019,999 sold of $4,509,472 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 15, 2019 · D · $2,914,590 sold of $3,500,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $15M from 6 investors (75% of the $20M target) as of the latest filing. Ann is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

BA
Other

Biobot Analytics, Inc.

Cambridge, MA · Aug 6, 2021 → Nov 17, 2021 · 2 filings
  • Nov 17, 2021 · D/A · $20,833,737 sold of $20,833,737 · 26 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 6, 2021 · D · $16,141,965 sold of $16,141,965 · 14 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $20.8M from 46 investors (100% of the $20.8M target) as of the latest filing. Ann is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

E
Biotechnology

E25Bio Inc.

Cambridge, MA · Aug 22, 2019 → Jun 1, 2021 · 4 filings
  • Jun 1, 2021 · D · $500,000 sold of $500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 19, 2020 · D · $2,000,000 sold of $2,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 26, 2020 · D · $2,000,000 sold of $3,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 22, 2019 · D · $2,299,970 sold of $2,299,970 · 7 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $2.3M from 7 investors (100% of the $500K target) as of the latest filing. Ann is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

KC
Biotechnology

Kytopen Corp.

Cambridge, MA · May 24, 2019 → Nov 6, 2020 · 2 filings
  • Nov 6, 2020 · D · $3,102,983 sold of $4,000,000 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 24, 2019 · D · $4,350,000 sold of $4,350,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $32.5M from 22 investors (100% of the $4M target) as of the latest filing. Ann is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

I
Biotechnology

ImmuneXcite, Inc.

Waltham, MA · Feb 1, 2017 → Feb 1, 2017 · 2 filings
  • Feb 1, 2017 · D · $2,672,359 sold of $3,000,000 · 47 investors · min. $512 · role: Director EDGAR ↗
  • Feb 1, 2017 · D/A · $8,920,848 sold of $10,920,143 · 81 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $8.92M from 81 investors (100% of the $3M target) as of the latest filing. Ann is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Ann DeWitt — TX, 1 issuer, Aug 19, 2019 → Nov 17, 2022 · no shared issuer

People around Ann 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

LV
No photo found yet (own website and image search run after this page is viewed)
Person

Livio Valenti

Executive Officer · 10 shared filings (2 issuers)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

KK
No photo found yet (own website and image search run after this page is viewed)
Person

Kathryn Kosuda

Executive Officer, Director · 8 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

JK
No photo found yet (own website and image search run after this page is viewed)
Person

Jonathan Kluge

Executive Officer · 8 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

LT
No photo found yet (own website and image search run after this page is viewed)
Person

Lynda Tussey

Executive Officer · 8 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

FE
No photo found yet (own website and image search run after this page is viewed)
Person

Fenel Eloi

Director · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

CA
No photo found yet (own website and image search run after this page is viewed)
Person

Carlos Araque

Executive Officer, Director · 6 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Schrader

Executive Officer, Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

AB
No photo found yet (own website and image search run after this page is viewed)
Person

Adam Behrens

Executive Officer, Director · 5 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

CC
No photo found yet (own website and image search run after this page is viewed)
Person

Colleen Calhoun

Director · 5 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Rachel Sha

Director, Executive Officer · 5 shared filings (2 issuers) · also on 2 other issuers

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

PK
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Kolchinsky

Director · 4 shared filings (1 issuer) · also on 19 other issuers

Peter Kolchinsky is on 20 issuers in total — a repeat sponsor. Their page lists every one.

WR
No photo found yet (own website and image search run after this page is viewed)
Person

William Restrepo

Director · 4 shared filings (1 issuer) · also on 4 other issuers

William Restrepo is on 5 issuers in total — a repeat sponsor. Their page lists every one.

MC
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Cupta

Director · 4 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

LM
No photo found yet (own website and image search run after this page is viewed)
Person

Lucas Mann

Director · 4 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

MB
No photo found yet (own website and image search run after this page is viewed)
Person

Mario Barro

Director · 4 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

AC
No photo found yet (own website and image search run after this page is viewed)
Person

Arunas Chesonis

Director · 3 shared filings (1 issuer) · also on 18 other issuers

Arunas Chesonis is on 19 issuers in total — a repeat sponsor. Their page lists every one.

LW
No photo found yet (own website and image search run after this page is viewed)
Person

Laura Witt

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

IB
No photo found yet (own website and image search run after this page is viewed)
Person

Irene Bosch

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

AR
No photo found yet (own website and image search run after this page is viewed)
Person

Amy Ripka

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

MD
No photo found yet (own website and image search run after this page is viewed)
Person

Matthew Dirckx

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

WT
No photo found yet (own website and image search run after this page is viewed)
Person

Weiner Tilsner

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

John Spiridigliozzi

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

SL
No photo found yet (own website and image search run after this page is viewed)
Person

Stanley Lapidus

Director · 2 shared filings (1 issuer) · also on 7 other issuers

Stanley Lapidus is on 8 issuers in total — a repeat sponsor. Their page lists every one.

JR
No photo found yet (own website and image search run after this page is viewed)
Person

John Ripple

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

JG
No photo found yet (own website and image search run after this page is viewed)
Person

James Geraghty

Director · 2 shared filings (1 issuer) · also on 4 other issuers

James Geraghty is on 5 issuers in total — a repeat sponsor. Their page lists every one.

JE
No photo found yet (own website and image search run after this page is viewed)
Person

John Edwards

Executive Officer, Director · 2 shared filings (1 issuer) · also on 4 other issuers

John Edwards is on 5 issuers in total — a repeat sponsor. Their page lists every one.

PS
No photo found yet (own website and image search run after this page is viewed)
Person

Purnanand Sarma

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

ER
No photo found yet (own website and image search run after this page is viewed)
Person

Eric Rowinsky

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

David Schechter

Director · 2 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

EF
No photo found yet (own website and image search run after this page is viewed)
Person

Eric Furfine

Executive Officer, Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

PG
No photo found yet (own website and image search run after this page is viewed)
Person

Paulo Garcia

Executive Officer, Director, Promoter · 2 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

CB
No photo found yet (own website and image search run after this page is viewed)
Person

Cullen Buie

Director · 2 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

MD
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Doiron

Director · 2 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

CS
No photo found yet (own website and image search run after this page is viewed)
Person

Craig Shapiro

Director · 2 shared filings (1 issuer) · also on 4 other issuers

Craig Shapiro is on 5 issuers in total — a repeat sponsor. Their page lists every one.

BH
No photo found yet (own website and image search run after this page is viewed)
Person

Bobby Brooke Herrera

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

NG
No photo found yet (own website and image search run after this page is viewed)
Person

Newsha Ghaeli

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

MG
No photo found yet (own website and image search run after this page is viewed)
Person

Mariana Guadalupe Matus Garcia

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

TH
No photo found yet (own website and image search run after this page is viewed)
Person

Ted Hibben

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

TT
No photo found yet (own website and image search run after this page is viewed)
Person

Theresa Tribble

Executive Officer, Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

JZ
No photo found yet (own website and image search run after this page is viewed)
Person

Jose Zevallos

Director · 2 shared filings (1 issuer)

Listed on the same filings as Ann DeWitt. Their page shows their other deals.

The team behind the deals

Same business address

43 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 10 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Ann DeWitt by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 10 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Ann DeWitt is listed on: none on file. No website or social profile named in Biobot Analytics, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #69,699 of 374,652 in line (16 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Cambridge, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Massachusetts MassCourts ↗Texas re:SearchTX court records ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Massachusetts Secretary of State business search ↗Texas Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Ann DeWitt appears on a new Form D, or when a court case or SEC action is matched to them. See plans →